Shenzhen Glory MedicalLtd Valuation
Is 002551 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 002551 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate 002551's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate 002551's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 002551?
Key metric: As 002551 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is 002551's PS Ratio? | |
|---|---|
| PS Ratio | 2.2x |
| Sales | CN¥1.28b |
| Market Cap | CN¥2.81b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.8x |
| Enterprise Value/EBITDA | -30.8x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 002551's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 3.7x | ||
002822 Shenzhen Zhongzhuang Construction GroupLtd | 0.9x | n/a | CN¥2.9b |
300977 Shenzhen Ridge Engineering Consulting | 6x | 15.4% | CN¥2.9b |
002887 Tianjin LVYIN Landscape and Ecology Construction | 5.6x | 1.5% | CN¥2.2b |
002811 Shenzhen Cheng Chung Design | 2.2x | n/a | CN¥2.4b |
002551 Shenzhen Glory MedicalLtd | 2.2x | n/a | CN¥2.8b |
Price-To-Sales vs Peers: 002551 is good value based on its Price-To-Sales Ratio (2.2x) compared to the peer average (3.7x).
Price to Sales Ratio vs Industry
How does 002551's PS Ratio compare vs other companies in the CN Construction Industry?
| 17 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
601668 China State Construction Engineering | 0.1x | 5.9% | US$34.04b |
601390 China Railway Group | 0.1x | 4.8% | US$20.09b |
601186 China Railway Construction | 0.1x | 2.4% | US$15.92b |
601669 Power Construction Corporation of China | 0.2x | 9.1% | US$13.16b |
| 17 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Sales vs Industry: 002551 is expensive based on its Price-To-Sales Ratio (2.2x) compared to the CN Construction industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is 002551's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 2.2x |
| Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate 002551's Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Beijing Sifang AutomationLtd
CN¥14.0b
Supplies power transmission, transformation protection, automation systems, power generation, enterprise power, and power distribution and consumption systems in China and internationally.
601126
CN¥16.77
7D
-9.4%
1Y
18.4%
China National Chemical Engineering
CN¥49.6b
An industrial engineering company, engages in the general contracting of construction, infrastructure, and overseas projects in the fields of chemical, petrochemical, pharmaceutical, power, and coal industries in China.
601117
CN¥8.12
7D
-5.1%
1Y
21.0%
Goneo Group
CN¥89.2b
Provides electrical products.
603195
CN¥68.98
7D
-5.8%
1Y
3.1%